Drug intelligence / Profile preview

JBE-01

Development stage: Preclinical
Lead developer: Jiangsu Jibeier Pharmaceutical
Modality: Small Molecules

Overview

JBE-01 is a small molecule drug candidate being developed by Jiangsu Jibeier Pharmaceutical for applications in anesthesia and pain management. Currently in the preclinical stage of development, the compound is part of the company's internal research pipeline. As of the current reporting, specific details regarding its biological target, mechanism of action, and chemical structure have not been publicly disclosed by the developer.

Beyond the preview

Go deeper on JBE-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JBE-01.

Explore the full profile